Arkolith/Insider Trading/FATE/Form 4

Xu Yuan

DirectorFATE THERAPEUTICS INC (FATE) · full profile →Form 4 · filed Jun 15, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2023Sell(S)3K$5.58$19K10K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-037302) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML